INTRODUCTION {#sec1}
============

Tuberculosis (TB) afflicted more than 10 million people and resulted in 1.7 million deaths in 2016 alone (World Health Organization, [@bib129]). Recent estimates suggest that currently 1.7 billion people, ∼1/4 of the global population, are latently infected with *Mycobacterium tuberculosis* (*Mtb*), the causative agent of TB (Houben and Dodd [@bib44]). *Mtb* is transmitted to new hosts via the respiratory route where it exists as a facultative intracellular pathogen that causes disease in approximately 10% of immunocompetent hosts. A hallmark of the host\'s immune response to *Mtb* is the formation of caseous granulomas---organized collections of immune cells, classically considered necrotic and hypoxic. There is growing appreciation, however, for the heterogeneity of granulomas, both within and between hosts (Barry *et al.*[@bib4]; Lenaerts, Barry and Dartois [@bib63]; Hunter [@bib46]). More specifically, granulomas manifest as lesions with differing degrees of cellularity, hypoxia, acidosis and necrosis; the success of *Mtb* as a pathogen, therefore, can be credited in part to its ability to monitor, respond to, and resist wide-ranging microenvironments within the host.

Interestingly, the stresses encountered by *Mtb* within the host can be considered within the framework of oxido-reductive stress. Hypoxia, acidity, carbon source availability, the respiratory burst of phagocytes and host-derived gasotransmitters like nitric oxide (NO) and carbon monoxide (CO) are all environmental forces that *Mtb* may encounter throughout the course of infection. These factors have the potential to impact major reduction-oxidation (redox) couples within *Mtb*, the transport of electrons or directly damage cellular components (Kumar *et al.*[@bib56]; Cumming *et al.*[@bib23]; Chinta *et al.*[@bib19]). In fact, host susceptibility to *Mtb* infection is in part determined by the host\'s ability to produce redox active compounds known as reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) (Lamichhane [@bib60]; Voskuil *et al.*[@bib122]). Additionally, the redox environment of the granuloma as well as the ability of *Mtb* to maintain redox homeostasis have been recognized as contributing factors in prolonged therapy and drug resistance in *Mtb* infection (Via *et al.*[@bib118]; Lanoix, Lenaerts and Nuermberger [@bib61]; Saini *et al.*[@bib92]).

Thus, it is necessary for *Mtb* to monitor and respond to numerous environmental factors to maintain redox homeostasis. This process requires *Mtb* to modify its activity to suit the dynamic demands of its microenvironment, ultimately achieving its pathogenic potential. By understanding the host\'s response to *Mtb* as well as *Mtb*'s response to the host, we may identify potential targets for host-directed and anti-bacterial therapies in TB.

SCOPE {#sec2}
=====

This review will focus on the molecular machinery that *Mtb* employs to sense and respond to various reductive and oxidative stresses encountered within the host. We will begin by discussing fundamental principles of redox reactions and how they are affected by environmental conditions. Next, we will review the systems within *Mtb* that are essential for maintaining redox homeostasis and responding to environmental redox stresses. Lastly, we will integrate these systems and describe their ability to coordinate an effective response to redox stresses. In sum, we propose a conceptual model of *Mtb* pathogenesis that features interactions between the host environment and *Mtb*.

FROM REDOX CHEMISTRY TO REDOX BIOLOGY {#sec3}
=====================================

To fully understand how *Mtb* senses and responds to shifting redox environments, an understanding of the fundamental concepts in redox chemistry is essential. We direct the reader to these excellent resources for additional reading on redox chemistry and biology (Schafer and Buettner [@bib98]; Halliwell and Gutteridge [@bib40]). Redox chemistry encompasses chemical reactions in which the oxidation state of participating molecules is changed through the gain or loss of electrons. A molecule is oxidized if it loses electrons, and it is reduced if it gains electrons. Redox biology can often be distilled into the activities of biologically relevant redox couples (Table [1](#tbl1){ref-type="table"}), each composed of the two states of a redox-active molecule: the oxidized state and the reduced state (e.g. NAD^+^/NADH).

###### 

Redox potentials of biologically relevant redox couples.
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Redox couples are ordered by increasing reduction potential (Δ*E*^o^΄). Δ*E*^o^΄ values were adjusted from the reduction potential under standard conditions to reflect the potential at a pH = 7 using the Nernst equation, as H^+^ is an important constituent of many of the couples in question. It is important to recognize that these values do not directly reflect Δ*E* values *in vivo*, as various conditions, including temperature and concentration of reactants can vary dramatically. Δ*E*^o^΄ values shown were originally reported by Schafer and Buettner ([@bib98]) and Halliwell and Gutteridge ([@bib40]).

The properties of redox-active molecules, such as the presence of polar groups or the ability to undergo a conformational change, contribute to their tendency to be in an oxidized or reduced state. This tendency can be described by the half-cell reduction potential, Δ*E*, which is determined experimentally under standard conditions (Δ*E^o^*) that are 1.0 M for solutes and ions or 1 atm for gases at 25°C and pH = 0. The reduction potential for an alternative set of fixed conditions is denoted by Δ*E*^o^΄. For example, it is useful to establish Δ*E*^o^΄ as the standard conditions above with the exception of pH = 7 for biologically relevant redox couples, as shown in Table [1](#tbl1){ref-type="table"}. The direction of a redox reaction under constant conditions can be determined by the relationship between the Δ*E* of each couple: the reduced member of a given redox couple will reduce the oxidized constituent of any other redox couple with a more positive Δ*E*^o^.

Major redox couples serve varied functions, including carrying electrons (e.g. NAD^+^/NADH, NADP^+^/NADPH) and maintaining redox homeostasis as a 'buffer' (e.g. glutathione/glutathione disulfide GSSG/GSH). Other couples composed of ROI and RNI, however, may threaten redox homeostasis. As their names suggest, ROI and RNI contain molecules with at least one redox-active oxygen or nitrogen atom, respectively. A number of important members of the ROI and RNI groups are also considered free radicals. The name indicates that these molecules are stable, or free, despite containing at least one unpaired electron, or radical. Key examples of ROI include the radicals O~2~^•−^ (superoxide), XO~2~^•^ (peroxyl radical) and XO^•^ (alkoxyl radical) and the non-radicals hydrogen peroxide (H~2~O~2~), ONOO^−^ (peroxynitrite, anion) and HOCl (hypochlorous acid). Examples of RNI include the radicals ^•^NO (nitric oxide, radical) and ^•^NO~2~, (nitrogen dioxide) and the non-radicals HNO~2~ (nitrous acid), NO^+^ (nitrosonium), NO^¯^ (nitroxyl anion), and others (Halliwell and Gutteridge [@bib40]).

ROI and RNI are feared mediators of oxidative stress and oxidative damage. Oxidative stress refers to an imbalance between ROI and the capacity of the cell to detoxify the species or repair cellular damage. Under these circumstances, the cell has a relatively higher Δ*E* and a decreased reductive capacity, as the abundance of oxidized species tends to oxidize other species in the cell. This can lead to oxidative damage if cellular components such as DNA or membrane lipids are damaged. The reductive capacity of a cell can often be defined by the central redox buffer in a cell, such as GSH/GSSG in most cells. Similarly, a cell can also experience reductive stress, a condition opposite to oxidative stress. Reductive stress can be conceptualized by an excess of electrons in a cell and exemplified by the loss of a terminal electron acceptor in or disruption of the central electron transport chain in a respiring cell. The threat of increased oxidative or reductive damage, therefore, underscores the importance of maintaining redox homeostasis within a cell.

One way cells maintain homeostasis is by coupling some reactions through the use of a common redox couple (e.g. NAD^+^/NADH, fatty acid catabolism) and separating these reactions from others by using a separate redox couple (e.g. NADP^+^/NADPH, fatty acid synthesis). This prevents certain reactions from reaching equilibrium, which generates redox potentials different from those measured under standard conditions and allows cells to manipulate their internal redox environment to their benefit. The impact various conditions have on the reduction potential of a redox reaction, including the concentration of the reactants, can be calculated with the Nernst equation: $$\documentclass[12pt]{minimal}
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{\rm{\Delta }}E{\rm{\ }} = {\rm{\ \Delta }}{E^o} - {\rm{\ }}\frac{{RT}}{{nF}}\ln Q
\end{equation*}\end{document}$$where R is the gas constant, *T* is the temperature in Kelvin, *n* is the number of electrons being transferred in the given reaction, *F* is the Faraday constant, and *Q* is the equilibrium constant calculated for the given reaction using the concentrations of the reactants and stoichiometry indicated by the balanced chemical equation. If the reaction is at equilibrium and *Q* = 1, then Δ*E* = Δ*E^o^*; it is therefore the concentration of reactants and the temperature that shift the favorability of reactions, processes, and the overall redox environment within a cell. H^+^ and O~2~, for example, are important environmental factors and participants in numerous redox reactions; the Nernst equation, then, provides information on how their availability influences redox homeostasis within a cell. Other factors, such as the availability of various carbon sources, their concentrations, or host-derived gasotransmitters capable of inhibiting metabolism can shape the overall redox environment within a cell secondary to affecting cell metabolism. These factors in particular bear relevance to the following discussion due to their variable presence within the tuberculous granuloma (Lenaerts, Barry and Dartois [@bib63]; Chinta *et al.*[@bib19]).

Gases, lipids, and other factors external to *Mtb* follow a heterogeneous distribution between and within granulomas due to variation in gross TB pathology, which ranges from early, non-necrotizing granulomas to necrotic and cavitating lesions to confluent collections of immune cells filling the available space within the lung (Lenaerts, Barry and Dartois [@bib63]). Features of a specific lesion type can generate inter- and intra-lesion heterogeneity; for example, a fibrotic rim present in some forms of TB pathology limits the oxygen within a necrotic granuloma and generates an oxygen gradient flowing from normoxia to extreme hypoxia toward the center of the granuloma (Datta *et al.*[@bib27]). Lesions can be dynamic, too. Progressive necrosis in the center of a lesion can shift the carbon source available to *Mtb* to lipid-rich caseum, which in some cases is thought to drain into an open airway to form a cavity (Lenaerts, Barry and Dartois [@bib63]). In this instance, oxygen is then able to reach the interior of the formerly hypoxic lesion. Through all of these conditions, *Mtb* exposure to host gases, such as NO and CO, as well as various oxidative species produced by the phagocyte oxidative burst, will vary, resulting in fluctuating, dynamic stresses on the pathogen.

MYCOBACTERIAL REDOX BUFFERS: ERGOTHIONEINE AND MYCOTHIOL {#sec4}
========================================================

One strategy that *Mtb* employs to survive in hostile oxidizing environments is to synthesize low molecular weight thiols to help it maintain a reducing environment and redox homeostasis (Fig. [1](#fig1){ref-type="fig"}) (Kumar *et al.*[@bib56]). In many cell types, including human cells, this role falls to glutathione (GSH) (Newton *et al.*[@bib70]; Venketaraman *et al.*[@bib117]). Interestingly, Mycobacteria do not produce GSH; rather, they synthesize two main types of thiols, ergothioneine (EGT) and mycothiol (MSH), which maintain intracellular redox balance during the course of infection (Kumar *et al.*[@bib56]; Saini *et al.*[@bib92]). Both are synthesized in mycobacteria via a multistep process involving multiple gene products encoded by the gene clusters *egtA-E* (EGT) and *mshA-D* (MSH) (Newton *et al.*[@bib72]; Seebeck [@bib101]). EGT contains a histidine as its core amino acid, and, at physiological pH, it exists as a thione that can be reduced to a disulfide form (Δ*E*^*o*^΄ = − 60 mV) (Jocelyn [@bib50]; Cumming *et al.*[@bib22]). MSH has cysteine as its core amino acid and, under the same conditions, exists as a thiol that can also be reduced to a disulfide (Δ*E*^*o*^΄ = − 230 mV) (Sharma *et al.*[@bib102]; Cumming *et al.*[@bib22]). The antioxidant properties of MSH result from the sulfur atom in the cysteine residue, which is active only in the reduced form (Rawat and Av-Gay [@bib78]). Reduced MSH can be oxidized to MSH disulfide (MSSM) in the context of oxidative stress, and MSSM can be converted back to the reduced state, MSH, by MSSM reductase in the presence of NADPH (Loi, Rossius and Antelmann [@bib65]). MSH serves as a cofactor for enzymes involved in the detoxification of peroxides, electrophiles and NO, and it is required for *Mtb* survival in the host (Sareen *et al.*[@bib97]; Buchmeier and Fahey [@bib10]; Rawat and Av-Gay [@bib78]; Newton, Buchmeier and Fahey [@bib71]).

![EGT and MSH Counter Oxidative Stress. Various exogenous factors can induce oxidative or nitrosative stress (yellow) in *Mtb*, leading to the generation of ROI and RNI. Major cytosolic redox buffers (orange), EGT and MSH, detoxify ROI/RNI, protect the cell from oxidative damage and contribute to virulence (red) by resisting anti-TB drugs and promoting survival.](fty036fig1){#fig1}

EGT and MSH appear to have overlapping as well as distinct roles within *Mtb*. Significantly increased levels of EGT were observed in a *Mtb*Δ*mshA* deletion mutant; however, lack of EGT in *egtA*:Tn, a transposon mutant of *Mtb* deficient in EGT production, did not lead to a corresponding increase in MSH (Saini *et al.*[@bib92]). Instead, the *egtA*:Tn mutant had a 25-fold increase in ROI-producing cells relative to wild-type *Mtb*, whereas the Δ*mshA* mutant had only an 8-fold increase in ROI producing cells relative to wild-type *Mtb*. This observation indicates that increased EGT production may compensate for a lack of MSH, but not vice versa. Additionally, transcriptome analysis of EGT and MSH mutants in *Mtb* revealed that while they serve similar functions, they also have distinct roles. These distinct roles may abrogate competition between the EGT and MSH biosynthetic pathways based on the redox status of the cell, allowing *Mtb* to synthesize the most appropriate buffer (Saini *et al.*[@bib92]).

Nonpathogenic, fast-growing *Mycobacterium smegmatis* (*Ms*) has also been used to study fundamental mechanisms of redox homeostasis in mycobacteria, as it is an appealing alternative to logistical challenges of *Mtb* research. *Ms* Δ*egtA* is highly sensitive to oxidative stress caused by cumene hydroperoxide (CHP), whereas Δ*egtD* is sensitive to lipid peroxides, tert-butyl hydroperoxide and CHP (Sao Emani *et al.*[@bib96]; Singh *et al.*[@bib107]). To this point *Ms*Δ*mshA* significantly increased levels of EGT by 26-fold in the exponential phase and 5-fold in the stationary phase (Ta *et al.*[@bib115]). Similar results were also observed in *Mtb* Δ*mshA* (Saini *et al.*[@bib92]). That being said, a *Ms* double mutant lacking both EGT and MSH is highly sensitive to peroxide stress compared to single mutants, which suggests that the functions of MSH and EGT might partly compensate for the function of other (Sao Emani *et al.*[@bib96]).

Additionally, EGT and MSH alter peroxide and drug susceptibilities in *Mtb*. Saini *et al.* ([@bib92]) showed that *egtA* and *egtD* transposon mutants of *Mtb* are significantly more sensitive to H~2~O~2~, CHP, paraquat and menadione, suggesting a role for EGT in protecting *Mtb* against oxidative stress. *Egt* mutants of *Mtb* are highly susceptible to anti-TB drugs such as rifampicin, isoniazid, clofazimine and bedaquiline. *Mtb*Δ*mshA*, was shown to be more susceptible to clofazimine and bedaquiline than wild-type and *egt* mutants. *Mtb* lacking MSH exhibited increased sensitivity towards rifampicin and streptomycin and decreased sensitivity towards isoniazid and ethionamide, suggesting that MSH may be required for the activation of some drugs while contributing to tolerance against others (Hernick [@bib41]). Overall, the shared and unique aspects of anti-TB drug susceptibilities in EGT and MSH mutants appear consistent with their shared and unique roles in maintaining redox homeostasis. This highlights an important relationship between maintaining redox homeostasis and survival.

In addition to its role in drug susceptibility, EGT also appears to be important to *Mtb* proliferation within murine cell lines and *in vivo*. Intracellular growth of *Mtb*Δ*egtA* and Δ*egtD* in murine RAW264.7 macrophages was reduced three-fold at 120 h post-infection, and the growth of *Mtb*Δ*egtD* mutant was reduced five-fold relative to wild-type *Mtb* at 120 h post-infection of murine J774A.1 macrophages (Richard-Greenblatt *et al.*[@bib82]; Saini *et al.*[@bib92]). These studies demonstrate that EGT is important for *Mtb* survival in macrophages. In addition, Saini *et al.* ([@bib92]) observed significantly reduced bacillary burden in the lungs of mice infected with *Mtb*Δ*egtA* and Δ*egtD* relative to wild type, establishing a role for EGT in *Mtb* pathogenesis. These findings complement the increased drug susceptibility in EGT mutants and suggest that EGT biosynthesis might be an attractive target for the development of new anti-TB therapeutic molecules intended to enhance existing therapies or provide a direct anti-mycobacterial effect.

MSH is also important to the virulence and survival of *Mtb*, as the loss of MSH biosynthesis and MSH-dependent detoxification inhibit the growth of mycobacteria (Sareen *et al.*[@bib97]; Hernick [@bib41]). In *Mtb* Erdman, the *mshA* and *mshC* genes are essential (Sareen *et al.*[@bib97]; Buchmeier and Fahey [@bib10]); interestingly, however, one group identified a spontaneous *mshA* mutant of *Mtb* H37RV that is resistant to ethionamide and that grows in immunodeficient mice but requires catalase for growth *in vitro* (Vilchèze *et al.*[@bib119]). This suggests important differences in the regulation of the redox environment may exist between different strains of *Mtb*. Survival of a *mshB* transposon mutant with only 20% wild-type MSH levels was markedly reduced in the presence of CHP; this mutant was resistant to H~2~O~2~, however, suggesting that 20% of MSH production is enough for *Mtb* to withstand oxidative stress caused by H~2~O~2~, in conjunction with other mechanisms for managing this stress (Buchmeier *et al.*[@bib9]). Enhanced killing of the *mshB* mutant under oxidative stress was observed during mid-exponential phase of growth, and the mutant also showed increased sensitivity to rifampicin, implicating MSH as an important part of *Mtb*'s survival strategy (Buchmeier *et al.*[@bib9]). Lastly, an earlier study showed that *Mtb*Δ*mshD* was sensitive to oxidative and acidic stress and showed reduced survival in macrophages (Buchmeier, Newton and Fahey [@bib8]). In this study, *Mtb*Δ*mshD* had higher levels of the MshD substrate, Cys-GlcN-Inositol, and produced a novel thiol, N-formyl-Cys-GlcN-Inositol; however, these molecules could not protect *Mtb* from the oxidative stress. The cumulative research on MSH biosynthesis demonstrates the importance of MSH in *Mtb* growth and withstanding oxidative stress, both endogenous and exogenous. Importantly, several studies have demonstrated that *Ms msh* mutants are sensitive to oxidative stress, antibiotic stresses, alkylating stress and low pH, strengthening the claim that MSH protects mycobacteria against various stresses and toxic agents (Newton *et al.*[@bib73]; Rawat *et al*. [@bib81], [@bib80], [@bib79]; Xu *et al.*[@bib134]).

The relationship between drug susceptibility and redox homeostasis was further established by a study from Bhaskar and colleagues ([@bib5]) that measured the changes in intra-mycobacterial MSH redox potential by coupling the MSH-dependent oxidoreductase, mycoredoxin 1, to redox sensitive GFP. Treatment of *Mtb* infected macrophages with anti-TB drugs led to an oxidative shift in the MSH redox potential, disrupting MSH homeostasis and leading to efficient killing of *Mtb*. Additionally, it was observed that mycobacteria with a higher MSH redox potential were more susceptible to antibiotics (Bhaskar *et al.*[@bib5]). In a follow up study, Mehta, Rajmani and Singh ([@bib69]) showed that *Mtb* WhiB3 responds to the acidic pH in macrophages during infection by modulating the MSH redox potential, which plays an important role in phagosomal maturation and virulence. This study showed that the redox sensitive WhiB3 and MSH are regulatory components mediating gene expression and are required to resist the acidic stress caused during *Mtb* infection (Mehta, Rajmani and Singh [@bib69]). The findings discussed in this section as well as the specificity of MSH expression in mycobacteria make MSH an attractive drug target for the treatment of TB with the added advantage that genes involved in biosynthesis of MSH are absent in humans (Rawat *et al.*[@bib79]; Newton, Buchmeier and Fahey [@bib71]; Gutierrez-Lugo *et al.*[@bib39]; Hernick [@bib41]).

THE MULTIFUNCTIONAL WHIB FAMILY {#sec5}
===============================

*Mtb* WhiB proteins are redox-sensing transcription factors of the WhiB-like (Wbl) family characterized by conserved Cys residues (Cys-X~n~-Cys-X~2~-Cys-X~5~-Cys; where X is an amino acid and n is a variable number) that coordinate an Fe--S cluster. There are seven members of the WhiB family in *Mtb*, namely WhiB1 (Rv3219), WhiB2 (Rv3260c), WhiB3 (Rv3416), WhiB4 (Rv3681c), WhiB5 (Rv0022c), WhiB6 (Rv3862c) and WhiB7 (Rv3197A) (Saini, Farhana and Steyn [@bib94]). Expression of these independent genes requires different stimuli, and their mRNA levels vary at mid-logarithmic growth phase. During the mid-logarithmic growth phase, *whiB1* was highly expressed and *whiB5* was poorly expressed relative to the other *whiB* genes that exhibited a similar number of mRNA copies as *sigA* (Larsson *et al.*[@bib62]). Likewise, these proteins share little sequence homology, and the microenvironment around their Fe-S clusters may vary considerably despite belonging to the same family. For example, the Fe--S cluster in WhiB3 contains multiple arginine (Arg) residues adjacent to the cluster-coordinating Cys residues (Cys~23~-Arg~24~-Cys~53~-Arg~54~-Arg~55~-Cys~56~-Cys~62~-Arg~63~). At neutral pH, these Arg residues may significantly lower the pKa of Cys, resulting in the formation of Cys thiolates. These thiolates are highly susceptible to oxidation that can lead to the loss of the Fe--S cluster (Saini *et al.*[@bib93]).

Owing to these differences, individual WhiB proteins also respond to different physiological stimuli such as hypoxia, NO and cyclic AMP, thereby augmenting their redox-sensitive function as transcription factors. Central to this role is the presence of an AT hook-like DNA binding motif that facilitates DNA binding. Hence, it can be argued that the unique physiochemical attributes of *Mtb* WhiB proteins facilitate a broad range of redox functionality that may explain their key roles in diverse aspects of *Mtb* biology. The reported roles of WhiB proteins in mycobacteria include their function as transcriptional regulators (all WhiB proteins), maintenance of redox homeostasis (WhiB3, WhiB4 and WhiB7), regulating protein secretion systems (WhiB1, WhiB5 and WhiB6), virulence (WhiB3, WhiB4, WhiB5 and WhiB6), antibiotic resistance (WhiB7) and reactivation from latency (WhiB1 and WhiB5) (Steyn *et al.*[@bib114]; Singh *et al.*[@bib106]; Smith *et al.*[@bib109]; Burian *et al*. [@bib11], [@bib12]; Chawla *et al.*[@bib16]; Solans *et al.*[@bib110]) (Fig. [2](#fig2){ref-type="fig"}).

WhiB3 is probably the most widely studied member of the WhiB family in *Mtb*. WhiB3 was shown to interact with the principal sigma factor of *Mtb*, SigA, and to be involved in *Mtb* virulence in mice (Steyn *et al.*[@bib114]). Subsequent studies have shown that WhiB3 modulates different aspects of *Mtb* pathogenesis. For example, as O~2~ can oxidize and NO can nitrosylate the WhiB3 Fe-S cluster, WhiB3 can respond to dormancy signals, including hypoxia and NO (Singh *et al.*[@bib105]). Furthermore, WhiB3 controls redox homeostasis in *Mtb* in part by modulating the production of redox buffer, EGT (Saini *et al.*[@bib92]). WhiB3 also facilitates maintenance of intracellular redox homeostasis by channeling reducing equivalents into lipid anabolism to produce polyketides such as phthiocerol dimycocerosate, triacylglycerol, and lipid cyclomodulins, which in turn impact the host cell-cycle during *Mtb* infection (Singh *et al.*[@bib105]). More recently, it was shown that *Mtb* infection blocks the G~1~/S transition in macrophages, and polyketides produced under WhiB3 control arrests the infected macrophages in the G~0~/G~1~ phase (Cumming *et al.*[@bib24]). Thus, WhiB3 manipulates the immune system and promotes long-term persistence by altering the host cell cycle of infected macrophages. Taken together, these studies firmly established that the redox-sensitive WhiB3 regulates aspects of *Mtb* virulence.

WhiB proteins have been implicated in modulating *Mtb* virulence by regulating the expression of 6 kDa early secretory antigenic target (ESAT-6) protein family secretion (ESX) systems also known as type VII secretion systems. ESX systems represent sophisticated secretory apparatuses that export a set of effector proteins, such as ESAT-6, which enables *Mtb* to evade the host immune response. WhiB6 and WhiB3 appear to regulate the expression of the ESX-1 (Bosserman *et al.*[@bib6]; Cumming *et al.*[@bib24]). WhiB3 specifically regulates genes that contribute to the ESX-1 system, including *esxA*, *esxB*, *espA*, *espC* and *espD* (Cumming *et al.*[@bib24]). Similarly, microarray analysis has shown that WhiB5 controls the expression of members of two other type VII secretion systems, namely ESX-2 and ESX-4 (Casonato *et al.*[@bib13]). This leads to speculation that *Mtb* modulates ESX expression through WhiB3, WhiB5 and WhiB6 to evade or suppress the immune system. Supporting this claim, both *whiB3* and *whiB5* mutants have both shown attenuation in murine models of TB (Steyn *et al.*[@bib114]; Casonato *et al.*[@bib13]).

Solans *et al.* ([@bib110]) observed that clinical TB strains secrete more ESAT-6 compared to lab-adapted *Mtb* strains. This phenomenon was ascribed to a genetic polymorphism in WhiB6 unique to the clinical strains. The reintroduction of a copy of *whiB6* from clinical strains to H37Rv increased ESAT-6 production and secretion to the level of clinical strains. Additionally, chromatin immunoprecipitation sequencing (ChIP-seq) and high-resolution transcriptomic studies showed that PhoP controls ESX-1 via EspR and ESX-1 expression is regulated by WhiB6 as part of the PhoP regulon (Solans *et al.*[@bib110]; Broset, Martín and Gonzalo-Asensio [@bib7]). As stated earlier, the ESX-1 secreted factor ESAT-6 is a major *Mtb* virulence factor; it can therefore be argued that alterations in *whiB6* impact virulence and pathogenicity of TB strains. A recent study by Chen *et al.* ([@bib17]) further advanced our understanding of WhiB6-mediated regulation of the ESX-1 cluster by showing WhiB6 differentially regulates both the ESX-1 and DosR regulons in *Mycobacterium marinum* (*Mm*), a species used to model *Mtb* infection in zebrafish, through environmental manipulation of the WhiB6 Fe-S cluster. The Fe-S cluster in WhiB6 is sensitive to oxidative and nitrosative stresses and plays an important role in regulating ESX-1 secretion as disruption of the intact Fe-S clusters in WhiB6 following exposure to O~2~ abolished the secretion of ESX-1 substrates (Chen *et al.*[@bib17]). The lack of ESX-1 substrates in the culture media of *Mm*Δ*whib6* is seemingly at odds with findings from Bosserman *et al.* ([@bib6]) who showed residual secretion of some ESX-1 components in *Mm*Δ*whiB6*. Though the *Mm* Δ*whib6* strains in both reports were virulent and induced hemolysis, these findings may be reconciled through the observation that low levels of ESX-1 activity are sufficient to translocate ESX-1 substrates to the cell surface of *Mm* and produce a virulent phenotype (Kennedy *et al.*[@bib52]). However, these levels of ESX-1 activity may or may not be high enough to detect these substrates in the culture media. Regardless, a clear role has emerged for WhiB6 in the regulation of ESX-1 and, subsequently, *Mtb* pathogenicity.

WhiB4 has been shown to regulate the PE/PPE gene family of mycobacteria. This gene family is unique to mycobacteria and contributes to the antigenic variation observed in *Mtb* (Gey van Pittius *et al.*[@bib37]). *Mtb* alone has 168 members in this gene family, and their secretion is reported to be regulated in part by the ESX-5 system, ESX-1 system, and several other regulators (Voskuil *et al.*[@bib123]; Houben *et al.*[@bib43]; Sani *et al.*[@bib95]; Fishbein *et al.*[@bib33]). Thus, the relationship of WhiB4, the PE/PPE gene family, and ESX expression may also impact the virulence of mycobacterial species. For example, Wu *et al.* ([@bib132]) showed WhiB4 is important for virulence of *Mm*. *Mm*Δ*whiB4* exhibited impaired replication in macrophages and diminished virulence in zebrafish. In contrast, *Mtb*Δ*whiB4* exhibited enhanced replication in macrophages and increased virulence in lungs of guinea pigs, although its dissemination to spleens was reduced (Chawla *et al.*[@bib16]). These seemingly contrasting roles for WhiB4 in *Mm* and *Mtb* were observed despite the high level of similarity in the WhiB4 proteins of the two species---83% identity in the amino acid sequence and 100% identity in the Cys-X~14--22~-Cys-X~2~-Cys-X~5~-Cys motif. Closer examination showed that, in *Mm*, a large number of *pe/ppe* genes (98) were regulated by WhiB4 compared to only three *pe/ppe* genes (*pe35, ppe19, ppe68*) in *Mtb* (Wu *et al.*[@bib132]). Considering the emerging evidence about a link between PE/PPE gene family members and regulation of ESX secretion systems, it is possible that differences in the expression of genes regulated by these proteins across different organisms may have uncovered an additional layer of complexity to WhiB functioning.

The complex nature of WhiB proteins is emphasized by an emerging, large body of research that fails to address more fundamental aspects of WhiB proteins, such as the redox potentials each of their Fe--S clusters. A major step forward in understanding WhiB biochemistry, however, came from the determination of the 3D structure of WhiB1, determined by nuclear magnetic resonance (Kudhair *et al.*[@bib54]). WhiB1 was shown to be a four-helix bundle with a core of three α-helices held together by an \[4Fe-4S\]^2+^ cluster. It also contains a cAMP receptor protein binding site. Its \[4Fe-4S\]^2+^ cluster is stable in the presence of O~2~ but is highly reactive to NO, as it reacts with eight equivalents of NO and yields two dinuclear dinitrosyl-iron thiol complexes. The Fe--S cluster, which is disassembled by nitrosylation, is required for WhiB1 to interact with the major sigma factor, SigA. On the other hand, NO mediated loss of the Fe--S cluster facilitates DNA binding to regulate the gene expression of different pathways, including repression of the *espA* operon that codes for proteins that are essential for the function of the major virulence factor ESX-1.

In sum, the sensitivity of WhiB proteins to environmental gases allows *Mtb* to differentially respond to stresses during infection by modulating the expression of various virulence factors (Fig. [2](#fig2){ref-type="fig"}).

![WhiB proteins regulate Mtb virulence. Mtb can encounter environments with various concentrations of O~2~ and NO within the host, leading to the development of intracellular redox stresses (yellow). (**A**) In the context of reductive stress, WhiB3 and WhiB6 (orange) adopt a conformation that promotes the transcription of genes involved in lipid synthesis while inhibiting the expression of ESX-1. These responses enhance *Mtb*'s ability to evade the immune system. (**B**) In the context of oxidative stress, WhiB3, Whib4 and WhiB5 (orange) contribute to increased virulence (red) by upregulating key virulence genes, including secretion systems ESX-2 and ESX-4. (**C**) Under nitrosative stresses, a number of WhiB proteins (orange) contribute to the transcription of genes involved in lipid synthesis while the inhibiting the expression of ESX-1 genes, and other processes involved in evasion of the immune system (red). While WhiB1 and WhiB4 are sensitive to NO, their involvement in this context remains unclear.](fty036fig2){#fig2}

THE DOS SYSTEM AND THE DORMANCY REGULON {#sec6}
=======================================

Perhaps one of the most important aspects of *Mtb* infection is the ability of *Mtb* to persist within the host for decades in a condition known as latent TB infection (LTBI). While patients with LTBI are asymptomatic, *Mtb* can 'reactivate' and cause disease after years or decades. The factors that contribute to latent and reactivation TB, however, remain poorly defined. One explanation is the ability of *Mtb* to enter and exit a state of extremely low metabolic activity under unfavorable or favorable conditions, respectively. This state, termed dormancy, is conceptually, but not yet empirically associated with the clinical condition LTBI, making it a topic of great interest. A collection of 48 genes induced as *Mtb* enters dormancy has been identified and is referred to as the Dos dormancy regulon (Voskuil *et al.*[@bib124]). Expression of the dormancy regulon is sensitive to O~2~, NO and CO and ultimately controlled by the Dos three-component system (Fig. [3](#fig3){ref-type="fig"}) (Voskuil *et al.*[@bib124]; Kumar *et al.*[@bib55]).

![DosR/S/T respond to reductive stress. Environmental factors such as hypoxia; the host-derived gasotransmitters, NO and CO; and a lipid-rich environment can induce reductive stress in Mtb. DosS and DosT are heme-kinase sensors that sense reductive stress or hypoxia, respectively. Both sensors can directly bind NO and CO to maintain signaling through the regulatory element, DosR, which induces the Dos dormancy regulon. The dormancy regulon is a collection of 48 genes theoretically involved in the induction of dormancy and the rewiring of metabolism. Fatty acid synthesis in particular is thought to be served as an electron sink to combat the reductive environment.](fty036fig3){#fig3}

DosS and DosT {#sec6-1}
-------------

Initially described as the DevR/S dormancy system (Dasgupta *et al.*[@bib26]; Saini *et al.*[@bib91]), the Dos system is composed of two histidine sensor-kinases, DosS and DosT, and a regulatory element, DosR, which acts as a transcription factor when phosphorylated by the upstream sensors (Roberts *et al.*[@bib85]). DosS and DosT are membrane-tethered proteins that contain a heme group and a histidine kinase essential for autophosphorylation and subsequent signaling (Chim, Johnson and Goulding [@bib18]). DosT is inactive when its heme is in the O~2~-bound state; as environmental O~2~ decreases (i.e. hypoxia), O~2~ dissociates from the heme group causing DosT to undergo autophosphorylation (Kumar *et al.*[@bib57]). Signaling through DosS, on the other hand, is dependent on the oxidation state of the iron in its prosthetic heme group; DosS is inactive when its heme iron is in the ferric (Fe^3+^) state, whereas it undergoes autophosphorylation when its heme iron is reduced to the ferrous (Fe^2+^) state (Kumar *et al.*[@bib57]). Initial experiments conducted *in vitro* also observed O~2~ binding directly to the DosS heme iron; these studies, however, were conducted at a partial pressure of O~2~ exceeding what is likely encountered within the host (Ioanoviciu *et al*. [@bib48], [@bib47]). Thus, the more plausible mechanism of *in vivo* signaling is that exposure to O~2~ induces autooxidation of the iron to the Fe^3+^ state, preventing signaling in an aerobic environment, while a reductant could reduce the heme-iron to the Fe^2+^ state and induce expression of the dormancy regulon (Kumar *et al.*[@bib57]; Honaker *et al.*[@bib42]). Furthermore, the responsiveness of these sensors to host gasotransmitters capable of inhibiting cellular metabolism, such as NO and CO, is thought to maintain or 'lock' the activated heme group in both DosS and DosT in a stable conformation, allowing both sensors to maintain active signaling (Kumar *et al*. [@bib57], [@bib55]). This coordinated response to various gases appears to be further augmented by the NO-sensitive serine/threonine protein kinase, PknH, which phosphorylates DosR at additional sites and appears to be required for the full induction of the Dos regulon (Chao *et al.*[@bib14]).

Hypoxia {#sec6-2}
-------

A progressively hypoxic environment induces the expression of genes and proteins within the dormancy regulon in *Mtb* (Gopinath *et al.*[@bib38]; Schubert *et al.*[@bib100]; Iona *et al.*[@bib49]; Kumari *et al.*[@bib58]). In the Wayne model of dormancy, the expression of these genes as well as the protein expression of DosR peaked during the induction of dormancy and decreased relative to peak expression during the remainder of dormancy, measured at day 40 at the latest (Gopinath *et al.*[@bib38]; Iona *et al.*[@bib49]). In a standing model of dormancy, however, transcripts of important genes were upregulated throughout dormancy with a peak expression between 60 and 90 days (Kumari *et al.*[@bib58]). In this study, the expression of the *dosR* and *tgs1* genes appears to follow an expression pattern similar to that observed in the study by Iona *et al.* ([@bib49]) through day 30; however, peak expression was observed beyond the latest time points in previous experiments. Though the difference in findings may be due to the use of different models, it is possible the dormancy regulon may be expressed at the highest levels well after the initial exposure to hypoxia at a time point not previously observed. Lastly, additional proteomic analysis estimated that proteins encoded in the dormancy regulon make up 20% of the proteome of *Mtb* throughout much of hypoxia-induced dormancy (Schubert *et al.*[@bib100]). In sum, it appears that genes and proteins of the dormancy regulon are expressed to varying extents throughout hypoxia-induced dormancy, and they may play roles in inducing, maintaining and emerging from dormancy.

Lipids {#sec6-3}
------

The source of carbon for *Mtb* has similarly been shown to impact the expression of genes within the dormancy regulon *in vitro*. Culturing *Mtb* in equal-length long chain fatty acids (LC-FAs) induces expression of more than half of the genes in the dormancy regulon (Rodríguez *et al.*[@bib89]). Interestingly, genes within this group, including the gene encoding triacylglycerol synthase, *tgs1*, are associated with *Mtb* lipid synthesis in lipid-rich, hypoxic environments (Daniel *et al.*[@bib25]). This suggests that reductive stress may be sufficient to induce the dormancy regulon. This is further supported by work from Honaker and colleagues who demonstrated a possible DosS-dependent signaling mechanism through which the excess electrons within a cell may be sensed (Honaker *et al.*[@bib42]). Sensing may occur through a direct interaction between the electron transport chain of the cell or perhaps through monitoring the balance of intracellular redox couples, such as NAD^+^/NADH. Recently, more nuanced studies have investigated the contribution different lipids make to gene expression in *Mtb*. The addition of cholesterol to media containing LC-FAs led to earlier induction of DosR-dependent genes thought to be essential to the reductive stress response, such as *tgs1* (Soto-Ramirez *et al.*[@bib113]). This was supported in a follow-up proteomic analysis of *Mtb* cultured in LC-FA media supplemented with cholesterol conducted by the same group (Garcia-Morales *et al.*[@bib34]). Together, these studies suggest that the dormancy regulon plays a role in responding to the availability of various carbon sources and the associated intracellular redox environment.

Vitamin C {#sec6-4}
---------

It appears that vitamin C may also induce the dormancy regulon. Taneja *et al.* ([@bib116]) found that physiological levels of vitamin C depleted O~2~ from *Mtb* cultures, induced the dormancy regulon, and produced a dormancy phenotype. A follow-up study revealed that in addition to the induction of the dormancy regulon, the overall transcriptional response to vitamin C treatment mimicked a number of other intracellular stresses, including oxidative and nitrosative stresses (Kumari *et al.*[@bib59]). This was supported by comprehensive study detailing the response of *Mtb* to vitamin C treatment that involved transcriptome remodeling of 67% of *Mtb* genes and the induction of a viable but non-culturable state in *Mtb*. Vitamin-C-treated *Mtb* in this state were resistant to rifampicin and isoniazid; however, killing of *Mtb* by pyrazinamide was potentiated to an extent that negated the effects of the aforementioned tolerance (Sikri *et al.*[@bib104]).

In contrast, another group determined that vitamin C kills *Mtb* by inducing high levels of ferrous iron in the cell and oxidative stress via the Fenton reaction, rather than inducing the dormancy regulon (Vilchèze *et al.*[@bib120]). The authors point to the repression of the *mbtD* gene as evidence for increased intracellular iron in *Mtb* following treatment with vitamin C; repression of *mbtD* in the context of high levels of iron, however, is dependent on the activity of *ideR* (Rodriguez *et al.*[@bib88]). Surprisingly, though, *ideR* was also downregulated in the gene expression data (Vilchèze *et al.*[@bib120]). Furthermore, the gene expression data did not reveal any change in the expression of genes encoding for proteins essential for the *Mtb* response to increased iron concentrations (Vilchèze *et al.*[@bib120]), such as bacterioferritin A and B (Rodriguez and Smith [@bib87]). Likewise, the gene for a key oxidative response regulator, *ahpD*, was also down regulated. Contrary to their *in vitro* findings, vitamin C treatment alone has no effect *in vivo*, though it appears to potentiate the effects of rifampicin and isoniazid combination therapy (Vilchèze, Kim and Jacobs [@bib121]). Notably, this stands in contrast with the tolerance of these drugs *in vitro*, reported by Sikri *et al.* ([@bib104]). A possible explanation is that the upregulation of *sodC*, *ahpC*, *katG* and MSH and EGT biosynthesis genes observed by Sikri *et al.* ([@bib104]) may counter the ROI-dependent actions of rifampin and isoniazid, thereby conferring resistance to these drugs (Wang, Burger and Drlica [@bib127]; Dwyer *et al.*[@bib29]; Piccaro *et al.*[@bib76]). While vitamin C would certainly be an appealing adjunct to TB therapies for logistical reasons alone, the discrepancies of its impact on *Mtb* and its effects *in vitro* highlight the need for further investigation.

The Dos system in Mtb pathogenesis {#sec6-5}
----------------------------------

The importance of DosR/S/T and the dormancy regulon to pathogenicity have been investigated in various animal models of TB, as well. Infection studies in C57BL/6J and SCID mice using *Mtb* lacking *dosR* showed no attenuation and, in one study, led to increased virulence compared to wild type (Parish *et al.*[@bib74]; Rustad *et al.*[@bib90]). The inability of most mouse strains to reproduce major aspects of human TB pathology, including hypoxic granulomas, has since been appreciated (Aly *et al.*[@bib1]; Ernst [@bib32]). Subsequent studies in C3HeB/FeJ mice that do form hypoxic, necrotic, and even cavitating lesions have demonstrated roles in *Mtb* virulence for specific components of the Dos system, though surprisingly not *dosR* (Gautam *et al.*[@bib35]; Gautam, Mehra and Kaushal [@bib36]). Compared to the H37Rv strain, Converse and colleagues ([@bib20]) observed a decreased bacterial burden in C57BL/6J mice, rabbits and guinea pigs infected with a *dosR/dosS* double mutant (Converse *et al.*[@bib20]). These results suggest that the Dos system may play a role in the survival and persistence of *Mtb* in potentially hypoxic environments, *in vivo*; however, the failure of any of these models to fully capture the environment of the human lungs must be noted (Ernst [@bib32]; Lenaerts, Barry and Dartois [@bib63]).

This issue was recently addressed using the non-human primate (NHP) model of TB, which most closely resembles human TB. Mehra *et al.* ([@bib67]) infected NHPs with *Mtb* lacking either *dosR*, *dosS* or *dosT*. These mutants displayed no defect in replication relative to WT and complemented *Mtb* strains; however, all three single mutants were compromised in their ability to cause disease and persist within the host. Not surprisingly, this phenotype was strongly associated with hypoxia described within the lesions of host NHPs and a more robust T-cell response to infection, suggesting that components of the Dos system or the downstream regulon may play a role in suppressing or evading the host immune response. The relationship between hypoxia and the expression of the dormancy regulon was further validated in the second study from this group, which found that the dormancy regulon was induced in *Mtb* in association with lesion hypoxia and latency in infected NHPs (Hudock *et al.*[@bib45]). It is interesting to note that the most hypoxic lesions also contained central necrosis and the subsequent accumulation of a lipid-rich caseum within the granuloma. Thus, these studies do not preclude a contribution of lipid metabolism to Dos system-mediated virulence or the expression of genes within the dormancy regulon *in vivo*. Ultimately, the major contribution of these two studies is identifying a direct link between hypoxia and the expression of genes involved in the dormancy regulon *in vivo* and demonstrating an essential role for the components of the Dos system in *Mtb* virulence in the model that most closely approximates human TB.

Lastly, the clinical relevance of the Dos system and dormancy regulon was recently investigated in HIV-positive and HIV-negative TB patients. The authors observed increased expression of genes within the dormancy regulon in the cells collected by bronchoalveolar lavage (BAL) from HIV uninfected patients (Walter *et al.*[@bib126]). The authors propose two possible explanations for this observation. The first is that impaired host immunity in HIV patients leads to disordered granuloma formation and a potentially increased oxygen tension in granulomas (Diedrich, O'Hern and Wilkinson [@bib28]). An alternative explanation stems from the analysis of host gene expression in the same BAL samples. Increased expression of the arginase gene and a decreased expression of the gene for inducible nitric oxide synthase in HIV infected patients suggest that macrophages in HIV infected patients were potentially less capable of producing NO, stressing *Mtb*, and inducing the dormancy regulon in *Mtb* (Walter *et al.*[@bib126]). Regardless, this finding underscores the importance of the host response on cellular activity of *Mtb* in human TB.

OTHER SYSTEMS FOR MAINTAINING REDOX HOMEOSTASIS {#sec7}
===============================================

SenX3-RegX3 {#sec7-1}
-----------

*Mtb* has a number of other systems important for responding to threats to redox homeostasis. Similar to DosR/S/T, the SenX3-RegX3 system is a two-component system that is sensitive to O~2~, NO and CO through the heme sensor kinase, SenX3 (Singh and Kumar [@bib108]). Available evidence suggests that SenX3 may operate as a redox sensor that signals under the opposite conditions as DosS and DosT; hypoxia, NO and CO increase the activity of DosS and DosT, whereas these factors decrease SenX3-dependent signaling (Singh and Kumar [@bib108]). It follows, then, that RegX3 would be active in the presence of O~2~ and the absence of NO and CO, though this has not been shown. Microarray data from a SenX3-RegX3 deletion mutant of *Mtb* demonstrate direct or indirect regulation of genes involved in the synthesis of DNA, RNA, lipids and cell wall components, as well as genes involved in lipid metabolism, suggesting that the SenX3-RegX3 system may serve to sense the suitability of the external environment for *Mtb* replication (Parish *et al.*[@bib75]). This is supported by evidence that SenX3-RegX3 mutants exhibit impaired growth after infecting macrophages and are attenuated in mice and guinea pigs (Parish *et al.*[@bib75]; Rickman *et al.*[@bib83]; Rifat, Bishai and Karakousis [@bib84]). More specifically, RegX3 appears to play a direct role in the regulation of *cydB*, g*ltA* and *ald*---three genes important for oxygen-dependent metabolism in *Mtb* (Roberts *et al.*[@bib86]).

Sigma factors {#sec7-2}
-------------

Specialized sigma factors also provide *Mtb* with transcriptional control in the context of redox stress. Specifically, SigH and SigE are important transcriptional regulators in the response to oxidative stress that share a number of striking similarities (Wu *et al.*[@bib133]; Raman *et al.*[@bib77]). Both recognize nearly identical promoter sequences with the exception of a discriminating base in the sixth position of the -35 hexamer (Song *et al.*[@bib112]; Sharp *et al.*[@bib103]), both are important to the pathogenesis of TB (Kaushal *et al.*[@bib51]; Ando *et al.*[@bib2]; Mehra *et al.*[@bib68]), and, importantly, both SigH and SigE are bound by redox-sensitive anti-sigma factors in a reducing environment and are released under oxidizing conditions (Song *et al.*[@bib111]; Barik *et al.*[@bib3]). Despite these similarities, SigH and SigE maintain functionally distinct roles.

Recently, Sharp *et al.* ([@bib103]) identified new members of the direct SigH regulon and expanded our understanding of its role in the response to oxidative stress. ChIP-seq analysis confirmed the regulation of genes for the antioxidant proteins thioredoxin and thioredoxin reductase, as well as various oxidoreductases, but it also identified genes important in mitigating oxidative damage. These include genes important in the synthesis and salvage of cysteine-containing proteins (*mec*, *cysO*, *cysM*, *moeZ* and *moeB1*), the repair of oxidized methionine residues (*msrB*), DNA repair (*udgB*) and ribosome replenishment (*rpmE*). In contrast, SigE appears to govern the transcription of genes involved in a general stress response, such as those encoding heat shock proteins (*hsp* and *htpX*) and enzymes involved in fatty acid oxidation (*aceA*, *fadB2*, *fadE24*, and *fadE23*; Manganelli *et al.*[@bib66]). However, the SigE regulon has not been as rigorously defined as the SigH regulon. Lastly, it appears that SigE may help *Mtb* survive oxidative stress by moderating the potentially harmful aspects of the WhiB4 response to such stress, such as nucleoid condensation (Chawla *et al.*[@bib15]). Thus, there is an appreciation for greater diversity in the activity of the redox-responsive transcriptional elements, SigH and SigE.

Serine/Threonine protein kinases {#sec7-3}
--------------------------------

PknH (mentioned above) and PknG are two serine/threonine protein kinases that have emerged as important players in the maintenance of redox homeostasis in *Mtb*. PknG contains a rubredoxin domain with two thioredoxin motifs that regulates its kinase activity (Scherr *et al.*[@bib99]). Initial studies identified important roles for PknG in *Mtb* survival in macrophages (Walburger *et al.*[@bib125]), antibiotic resistance (Wolff *et al.*[@bib131]) and virulence *in vivo* (Cowley *et al.*[@bib21]). More recent studies show that these phenotypes are dependent, at least in part, on the maintenance of redox homeostasis by PknG through the regulation of the Nudix hydrolase, RenU (Wolff *et al.*[@bib130]), and the metabolic regulator, GarA (Khan *et al.*[@bib53]). *Mtb* mutants lacking either PknG or RenU exhibited decreased survival relative to WT *Mtb* when exposed to H~2~O~2~ and diamide (Wolff *et al.*[@bib130]). Additionally, *M. smegmatis* mutants lacking PknG or RenU accumulated the RenU substrates NADH and FAD following exposure to H~2~O~2~. Ultimately, it was shown that a ribosomal protein, L13, was capable of enhancing RenU activity following phosphorylation by PknG, establishing a redox homeostatic system under the control of PknG that is important for *Mtb* survival within macrophages. In addition, PknG may regulate redox homeostasis via phosphorylation of GarA. An *Mtb* mutant lacking PknG exhibited a wider range of redox environments between stressed and unstressed conditions, which was associated with decreased viability in the Wayne model of hypoxia-induced dormancy and when grown on nutrient-limited media (Khan *et al.*[@bib53]). Under hypoxic conditions, PknG promoted survival of *M. smegmatis* by reprogramming metabolism via phosphorylation of GarA, a regulator of key steps in the TCA cycle. Taken together, this work expands the role of PknG from withstanding oxidative stress within macrophages to a role as a central redox regulator capable of managing instances of reductive and oxidative stress during infection and dormancy-inducing conditions, ultimately making it a more attractive therapeutic target.

Enzymatic detoxification of ROI {#sec7-4}
-------------------------------

Other enzymes in *Mtb* exist to counteract specific ROI or RNI; for example, superoxide dismutases (SODs) and catalases directly counter O~2~^•−^ and H~2~O~2~, respectively (Ehrt and Schnappinger [@bib31]). SODs are metalloproteinases responsible for the conversion of O~2~^•−^ to H~2~O~2~ that can then be converted into OH^−^ by catalase. *Mtb* catalase KatG also has the ability to detoxify other peroxides as well as peroxynitrite (ONOO^−^) (Wengenack *et al.*[@bib128]). These enzymes are considered virulence factors for *Mtb* and aid in countering oxidative stress from exogenous sources, including the phagocyte respiratory burst (Li *et al.*[@bib64]; Edwards *et al.*[@bib30]). Several other enzymes are important for the detoxification of specific ROI and RNI, and a full discussion of these would exceed the scope of this review. For an in depth discussion on *Mtb* strategies to directly counter such stresses, we direct the reader to the following review (Ehrt and Schnappinger [@bib31]). These particular examples, however, illustrate the specificity of the *Mtb* armament against ROI and RNI.

CONCLUSIONS AND DIRECTIONS {#sec8}
==========================

We have described numerous factors encountered by *Mtb* during infection, as well as the major cellular machinery coordinate an output that allows it to adapt to the presence, absence or a mix of these factors (Fig. [4](#fig4){ref-type="fig"}). The variable presence of these factors contributes to the dynamic, heterogeneous environment within the host, comprising an important aspect of *Mtb* pathogenesis. While great strides have been made in the last few years, many fundamental aspects of *Mtb* redox physiology still elude us.

![Mtb senses and responds to its redox environment. Hypoxia, gasotransmitters and lipid metabolism saturate the electron transport chain and electron carriers within the cell, inducing reductive stress (left). Elements responsive to reductive stress (left) execute a coordinated output, involving fatty acids synthesis to counter reductive stress and inhibit aspects of the immune response, expression of proteins important in the induction of dormancy, and decreasing the expression of highly antigenic secretion systems. On the other end of the spectrum, increased oxygen, the presence of numerous anti-TB drugs, and the respiratory burst of host phagocytes (right) can induce intracellular oxidative stress and ROI capable of damaging DNA, lipids and proteins. EGT and MSH can protect the cell by detoxifying ROI, promoting survival and resistance to drugs. WhiB proteins respond by upregulating the expression of secretion systems ESX-2 and ESX-4 (right). Ultimately, the ability of Mtb to sense and respond to a dynamic redox environment during infection is essential for Mtb virulence and pathogenesis.](fty036fig4){#fig4}

For example, fundamental facts regarding redox buffers, such as the reduction potentials of MSH and EGT *in vivo* remain unknown. We partially understand the impact of these redox buffers on drug susceptibility and resisting exogenous ROI; however, the significance of *Mtb* utilizing two major redox buffers as opposed to one is unclear. The ability of MSH or EGT to compensate for the other may provide an obvious advantage for a bacterium that must withstand significant oxidative stress prior to escaping the phagosome. However, it is possible that the existence of two major redox buffers may provide other advantages for *Mtb*. This remains an area of open speculation and investigation.

Similarly, most fundamental aspects of WhiB protein physiology are unknown. The redox potentials for the iron-sulfur clusters common to this family have not been determined, and the 3D structures of WhiB proteins remain unsolved, with the notable exception of WhiB1 (Kudhair *et al.*[@bib54]). The relationship between these proteins and *Mtb* virulence is an exciting area of investigation, given the ability of these proteins to positively and negatively regulate the expression of numerous genes in diverse redox environments. Special attention should be paid to the relationship of these proteins and the expression of secretion systems central to the virulence of *Mtb*.

In contrast, the fundamental aspects of the components of the DosR/S/T system are relatively well characterized in terms of their structure, responsive elements and signaling pathways. Recent work by Mehra *et al.* ([@bib67]) and Hudock *et al.* ([@bib45]) established the Dos system as an essential part of *Mtb* virulence *in vivo* and that the expression of genes within the Dos dormancy regulon is associated with local hypoxia. A link between induction of the dormancy regulon and dormant *Mtb*, however, has yet to be conclusively established *in vivo*. A mechanistic explanation for *Mtb* persistence within the host would address a crucial question in the TB field and would truly represent a substantial advance in our understanding of *Mtb* pathogenesis.

Regarding redox physiology, many of the redox-sensitive systems in *Mtb* play a role in drug resistance and susceptibility. This includes both major redox buffers, members of the WhiB family, and components of the DosR/S/T system. Notably these systems and their activity do not always convey resistance to drugs; for example, *Mtb* lacking MSH showed increased susceptibility to some drugs (e.g. rifampicin and streptomycin) while resistance to others (e.g. ethionamide and isoniazid). Such insights highlight the intricate interactions of anti-TB drugs and the redox machinery of *Mtb* as well as the potential of these cellular components as targets for adjunct therapies to existing anti-TB drugs. Their unique expression within the pathogen alone makes them excellent targets for novel anti-TB drugs.

Ultimately, great strides have been made in the past decade in understanding how *Mtb* senses and responds to our best efforts to eradicate it from our bodies. The essential nature of many of the components *Mtb* uses to this end speak to the significance of sensing and reacting to the dynamic redox environments within the host. The remaining gaps in our understanding of these cellular components and their place in the pathogenesis of TB, therefore, hold promise in addressing the TB crisis.
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